CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project investigates the interplay between cell cycle regulation and redox signaling in cancer. By using advanced genetic engineering and 3D cell culture models, it aims to understand how reactive oxygen species influence cell proliferation and identify potential therapeutic targets for cancer treatment.
Aberrant cell cycle and redox regulation are hallmarks of cancer.
While cell cycle and redox signaling are extensively studied, it remains poorly understood how both communicate in physiological conditions.
One reason is the emphasis on oxidative stress as a signature of cancer cells.
Only recently, emerging evidence indicates that reactive oxygen species (ROS) also function as signaling molecules in physiological conditions, and that some of their key targets are cysteine residues on cell cycle…
INSTITUTE OF CANCER RESEARCH: THE ROYAL CANCER HOSPITAL LBG
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, Dresden
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
